M3, Inc. Reports Consolidated Earnings Results for the First Quarter Ended June 30, 2019; Provides Consolidated Earnings Guidance for the First Half of 2020 and Full Year Ending March 31, 2020
July 25, 2019 at 07:00 am
Share
M3, Inc. reported consolidated earnings results for the first quarter ended June 30, 2019. For the quarter, the company reported net sales of ¥30,766 million against ¥26,898 million a year ago. Operating profit was ¥8,901 million against ¥7,840 million a year ago. Net profit was ¥5,982 million against ¥5,398 million a year ago. Basic earnings per share were ¥7.24 against ¥7.14 a year ago. Diluted earnings per share were ¥7.24 against ¥7.13 a year ago.
For the first half of 2020, the company expects consolidated net sales of ¥60,000 million, operating profit of ¥15,000 million, net profit of ¥10,300 million and basic earnings per share of ¥13.41.
For the year ending March 31, 2020, the company expects consolidated net sales of ¥130,000 million, operating profit of ¥35,000 million, net profit of ¥24,000 million and basic earnings per share of ¥32.43.
M3, Inc. specializes in the provision of online services dedicated to the health field. Net sales (before intra-group eliminations) break down by activity as follows:
- medical marketing support services (40.3%): services enabling doctors and health professionals to search for medical resources, use the latest medical news, exchange opinions, learn about medical products and services and career development, etc. via m3.com., MR-kun, MDLinx and MEDI: GATE;
- support services to medical institutions (16.5%):
- clinical trial related services (10.7%): clinical trial support and clinical trial operations management services;
- human resources services (6.6%);
- other (1.6%): including marketing assistance and surveys of affiliated medical companies via specialized sites.
The balance of sales (24.3%) concerns international activities.
M3, Inc. Reports Consolidated Earnings Results for the First Quarter Ended June 30, 2019; Provides Consolidated Earnings Guidance for the First Half of 2020 and Full Year Ending March 31, 2020
M3, INC. 
